Dynavax Technologies | 보통주 자본





보통주 자본 변화 날짜
AbbVie USD 1.77B 1.75B 2025-06
Adma Biologics USD 236.62M 242K 2024-12
Agenus USD 266K 30K 2025-03
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Dynavax Technologies USD 117.23M 117.11M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
Glaxosmithkline GBP 4.03B 2.68B 2025-09
Merck USD 2.49B 15.79M 2025-09
Minerva Neurosciences USD 1000 0 2024-09
Nektar Therapeutics USD 19K 0 2024-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Novartis USD 1.94B 23.4M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
TG Therapeutics USD 155.21M 2.81M 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


Dynavax Technologies 보통주 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.